Amy Roberts
Family Medicine · Town And Country, MONPI 1003894775
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Astellas Pharma US Inc at 58.7% of the total. Reporting peaked in 2022 at $4,463 and has fallen 95.0% since, to $222 in 2025. Among family medicine clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $50.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$4K
- Modernatx, Inc.$867
- Lilly USA, LLC$504
- Novo Nordisk$409
- AbbVie$349
- Pfizer$180
- plus $794 from 20 others
Across 1,578 payments — averaging $2553.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$4M
What the payments were for
- Consulting fees$3,06141%
- Travel & lodging$1,49820%
- Food & beverage$2,89639%
- Education$501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 7 | $4,402 |
| Modernatx, Inc. | 8 | $867 |
| Lilly USA, LLC | 27 | $504 |
| Novo Nordisk | 27 | $409 |
| AbbVie(2 entities) | 17 | $349 |
| Pfizer | 11 | $180 |
| E.r. Squibb & Sons, L.L.C. | 7 | $106 |
| Currax Pharmaceuticals LLC | 6 | $105 |
| Amarin Pharma, Inc. | 6 | $86 |
| AstraZeneca | 5 | $70 |
| Amgen | 3 | $43 |
| Sanofi-aventis U.S. LLC | 3 | $39 |
| Dexcom, Inc. | 3 | $38 |
| Merck | 2 | $37 |
| GE HealthCare | 1 | $31 |
| Johnson & Johnson | 2 | $30 |
| Eisai Inc. | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| GSK | 2 | $23 |
| Abbott | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| Optinose US, Inc. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Nalpropion Pharmaceuticals LLC | 1 | $15 |
How this compares
$7,505 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $21,208 |
| MounjaroTirzepatide | 19 | $17,999 |
| LinzessLinaclotide | 16 | $14,491 |
| GemtesaVibegron | 14 | $12,398 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $4,117 |
| SynthroidLevothyroxine Sodium | 37 | $2,892 |
| Dexlansoprazole DrDexlansoprazole | 11 | $1,762 |
| Balsalazide Disodium | 13 | $1,279 |
| Bupropion XlBupropion Hcl | 37 | $1,236 |
| Ezetimibe | 49 | $1,123 |
| Levothyroxine Sodium | 82 | $1,089 |
| Estradiol | 19 | $1,010 |
| Gabapentin | 47 | $708 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $621 |
| Duloxetine Hcl | 16 | $587 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $409 | $21,20823 claims |
| Lilly USA, LLCMounjaro | $504 | $17,99919 claims |
| AbbVieLinzess, Synthroid | $349 | $17,38353 claims |
| GSKIncruse Ellipta | $23 | $4,11711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Town And Country
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.